Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis

Authors: Kiran I Masood, Martin E Rottenberg, Naseem Salahuddin, Muhammad Irfan, Nisar Rao, Berit Carow, Muniba Islam, Rabia Hussain, Zahra Hasan

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Appropriate immune activation of T cells and macrophages is central for the control of Mycobacterium tuberculosis infections. IFN-γ stimulated responses are lowered in tuberculosis (TB), while expression of Suppressor of Cytokine Signaling (SOCS) molecules – 1 and 3 and CD4+CD25+FoxP3+T regulatory cells is increased. Here we investigated the association of these molecules in regard to clinical severity of TB.

Methods

Peripheral blood mononuclear cells (PBMCs) were isolated from patients with pulmonary TB (PTB, n = 33), extra-pulmonary TB (ETB, n = 33) and healthy endemic controls (EC, n = 15). Cases were classified as moderately advanced or far advanced PTB, and less severe or severe disseminated ETB. M. tuberculosis -stimulated IFN-γ, SOCS1, SOCS3 and FoxP3 gene expression and secretion of Th1 and Th2 cytokines was measured. Statistical analysis was performed using Mann–Whitney U, Wilcoxon Rank and Kruskal Wallis non-parametric tests.

Results

In un-stimulated PBMCs, IL-6 (p = 0.018) and IL-10 (p = 0.013) secretion levels were increased in PTB while IL-10 was also increased in ETB (p = 0.003), all in comparison with EC. M. tuberculosis-stimulated IL-6 (p = 0.003) was lowered in ETB as compared with EC. SOCS1 mRNA expression in M. tuberculosis stimulated PBMCs levels in moderately advanced PTB (p = 0.022), far advanced (p = 0.014) PTB, and severe ETB (p = 0.009) were raised as compared with EC. On the other hand, SOCS1 mRNA titers were reduced in less severe ETB, in comparison with severe ETB (p = 0.027) and far advanced PTB (p = 0.016). SOCS3 mRNA accumulation was reduced in far advanced PTB (p = 0.007) and FoxP3 mRNA expression was increased in less severe ETB as compared with EC (p = 0.017).

Conclusions

The lowered SOCS1 mRNA levels in patients with less severe extra-pulmonary TB as compared to those with more severe ETB and PTB may lead to elevated IFN-γ pathway gene expression in the latter group. As localized ETB has shown to be associated with more effective Th1 immunity and adaptive responses, this suggests a role for SOCS1 in determining disease outcome in extra-pulmonary TB.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: Tuberculosis Factsheet. 2011, Geneva: World Health Organisation WHO: Tuberculosis Factsheet. 2011, Geneva: World Health Organisation
2.
go back to reference WHO: Global Tuberculosis Control. 2011, Geneva: World Health Organisation WHO: Global Tuberculosis Control. 2011, Geneva: World Health Organisation
3.
go back to reference Stenger S, Modlin RL: T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol. 1999, 2 (1): 89-93. 10.1016/S1369-5274(99)80015-0.CrossRefPubMed Stenger S, Modlin RL: T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol. 1999, 2 (1): 89-93. 10.1016/S1369-5274(99)80015-0.CrossRefPubMed
4.
go back to reference Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted Interferon-gamma genes. Science. 1993, 259 (5102): 1739-1742. 10.1126/science.8456300.CrossRefPubMed Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted Interferon-gamma genes. Science. 1993, 259 (5102): 1739-1742. 10.1126/science.8456300.CrossRefPubMed
6.
go back to reference Qiu L, Huang D, Chen CY, Wang R, Shen L, Shen Y, Hunt R, Estep J, Haynes BF, Jacobs WR, et al: Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis. 2008, 198 (10): 1514-1519. 10.1086/592448.CrossRefPubMedPubMedCentral Qiu L, Huang D, Chen CY, Wang R, Shen L, Shen Y, Hunt R, Estep J, Haynes BF, Jacobs WR, et al: Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis. 2008, 198 (10): 1514-1519. 10.1086/592448.CrossRefPubMedPubMedCentral
7.
go back to reference Flynn JL, Chan J: Immunology of tuberculosis. Annu Rev Immunol. 2001, 19: 93-129. 10.1146/annurev.immunol.19.1.93.CrossRefPubMed Flynn JL, Chan J: Immunology of tuberculosis. Annu Rev Immunol. 2001, 19: 93-129. 10.1146/annurev.immunol.19.1.93.CrossRefPubMed
8.
go back to reference Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, et al: Depressed T-cell Interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis. 1999, 180 (6): 2069-2073. 10.1086/315114.CrossRefPubMed Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, et al: Depressed T-cell Interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis. 1999, 180 (6): 2069-2073. 10.1086/315114.CrossRefPubMed
9.
go back to reference Sharma SK, Mitra DK, Balamurugan A, Pandey RM, Mehra NK: Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol. 2002, 22 (6): 345-352. 10.1023/A:1020604331886.CrossRefPubMed Sharma SK, Mitra DK, Balamurugan A, Pandey RM, Mehra NK: Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol. 2002, 22 (6): 345-352. 10.1023/A:1020604331886.CrossRefPubMed
10.
go back to reference Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, Danusantoso H, Nelwan RH, Marzuki S, van der Meer JW, van Crevel R, et al: Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun. 2007, 75 (2): 820-829. 10.1128/IAI.00602-06.CrossRefPubMed Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, Danusantoso H, Nelwan RH, Marzuki S, van der Meer JW, van Crevel R, et al: Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun. 2007, 75 (2): 820-829. 10.1128/IAI.00602-06.CrossRefPubMed
11.
go back to reference Jamil B, Shahid F, Hasan Z, Nasir N, Razzaki T, Dawood G, Hussain R: Interferon gamma/IL-10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb). 2007, 87 (4): 279-287. 10.1016/j.tube.2007.03.004.CrossRef Jamil B, Shahid F, Hasan Z, Nasir N, Razzaki T, Dawood G, Hussain R: Interferon gamma/IL-10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb). 2007, 87 (4): 279-287. 10.1016/j.tube.2007.03.004.CrossRef
12.
go back to reference Gazzola L, Tincati C, Gori A, Saresella M, Marventano I, Zanini F: FoxP3 mRNA expression in regulatory T cells from patients with tuberculosis. Am J Respir Crit Care Med. 2006, 174 (3): 356-author reply 357CrossRefPubMed Gazzola L, Tincati C, Gori A, Saresella M, Marventano I, Zanini F: FoxP3 mRNA expression in regulatory T cells from patients with tuberculosis. Am J Respir Crit Care Med. 2006, 174 (3): 356-author reply 357CrossRefPubMed
13.
go back to reference Shevach EM: Mechanisms of FoxP3+ T regulatory cell-mediated suppression. Immunity. 2009, 30 (5): 636-645. 10.1016/j.immuni.2009.04.010.CrossRefPubMed Shevach EM: Mechanisms of FoxP3+ T regulatory cell-mediated suppression. Immunity. 2009, 30 (5): 636-645. 10.1016/j.immuni.2009.04.010.CrossRefPubMed
14.
go back to reference Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A: Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med. 2006, 173 (7): 803-810. 10.1164/rccm.200508-1294OC.CrossRefPubMed Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A: Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med. 2006, 173 (7): 803-810. 10.1164/rccm.200508-1294OC.CrossRefPubMed
15.
go back to reference Lesho E, Forestiero FJ, Hirata MH, Hirata RD, Cecon L, Melo FF, Paik SH, Murata Y, Ferguson EW, Wang Z, et al: Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis (Edinb). 2011, 91 (5): 390-399. 10.1016/j.tube.2011.07.002.CrossRef Lesho E, Forestiero FJ, Hirata MH, Hirata RD, Cecon L, Melo FF, Paik SH, Murata Y, Ferguson EW, Wang Z, et al: Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis (Edinb). 2011, 91 (5): 390-399. 10.1016/j.tube.2011.07.002.CrossRef
16.
go back to reference Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, et al: An Interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010, 466 (7309): 973-977. 10.1038/nature09247.CrossRefPubMedPubMedCentral Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, et al: An Interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010, 466 (7309): 973-977. 10.1038/nature09247.CrossRefPubMedPubMedCentral
17.
go back to reference Almeida AS, Lago PM, Boechat N, Huard RC, Lazzarini LC, Santos AR, Nociari M, Zhu H, Perez-Sweeney BM, Bang H, et al: Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol. 2009, 183 (1): 718-731. 10.4049/jimmunol.0801212.CrossRefPubMed Almeida AS, Lago PM, Boechat N, Huard RC, Lazzarini LC, Santos AR, Nociari M, Zhu H, Perez-Sweeney BM, Bang H, et al: Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol. 2009, 183 (1): 718-731. 10.4049/jimmunol.0801212.CrossRefPubMed
18.
go back to reference Wormald S, Zhang JG, Krebs DL, Mielke LA, Silver J, Alexander WS, Speed TP, Nicola NA, Hilton DJ: The comparative roles of Suppressor of Cytokine Signaling-1 and −3 in the inhibition and desensitization of cytokine signaling. J Biol Chem. 2006, 281 (16): 11135-11143. 10.1074/jbc.M509595200.CrossRefPubMed Wormald S, Zhang JG, Krebs DL, Mielke LA, Silver J, Alexander WS, Speed TP, Nicola NA, Hilton DJ: The comparative roles of Suppressor of Cytokine Signaling-1 and −3 in the inhibition and desensitization of cytokine signaling. J Biol Chem. 2006, 281 (16): 11135-11143. 10.1074/jbc.M509595200.CrossRefPubMed
19.
go back to reference Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Forster I, Clausen BE, et al: SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol. 2003, 4 (6): 540-545. 10.1038/ni931.CrossRefPubMed Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Forster I, Clausen BE, et al: SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol. 2003, 4 (6): 540-545. 10.1038/ni931.CrossRefPubMed
20.
go back to reference Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, Rossaint R, Heinrich PC, Muller-Newen G: Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by Suppressor of Cytokine Signaling 3. J Immunol. 2003, 170 (6): 3263-3272.CrossRefPubMed Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, Rossaint R, Heinrich PC, Muller-Newen G: Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by Suppressor of Cytokine Signaling 3. J Immunol. 2003, 170 (6): 3263-3272.CrossRefPubMed
21.
go back to reference Somoskovi A, Zissel G, Zipfel PF, Ziegenhagen MW, Klaucke J, Haas H, Schlaak M, Muller-Quernheim J: Different cytokine patterns correlate with the extension of disease in pulmonary tuberculosis. Eur Cytokine Netw. 1999, 10 (2): 135-142.PubMed Somoskovi A, Zissel G, Zipfel PF, Ziegenhagen MW, Klaucke J, Haas H, Schlaak M, Muller-Quernheim J: Different cytokine patterns correlate with the extension of disease in pulmonary tuberculosis. Eur Cytokine Netw. 1999, 10 (2): 135-142.PubMed
22.
go back to reference Hasan Z, Jamil B, Ashraf M, Islam M, Yusuf MS, Khan JA, Hussain R: ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis. PLoS One. 2009, 4 (4): e5158-10.1371/journal.pone.0005158.CrossRefPubMedPubMedCentral Hasan Z, Jamil B, Ashraf M, Islam M, Yusuf MS, Khan JA, Hussain R: ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis. PLoS One. 2009, 4 (4): e5158-10.1371/journal.pone.0005158.CrossRefPubMedPubMedCentral
23.
go back to reference Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, Zajdowicz MJ, Scarborough R, LoBue PA, Lardizabal AA, Daley CL, et al: Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS One. 2011, 6 (11): e26545-10.1371/journal.pone.0026545.CrossRefPubMedPubMedCentral Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, Zajdowicz MJ, Scarborough R, LoBue PA, Lardizabal AA, Daley CL, et al: Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS One. 2011, 6 (11): e26545-10.1371/journal.pone.0026545.CrossRefPubMedPubMedCentral
24.
go back to reference WHO: Treatment of Tuberculosis: Guidelines for National Programmes. 2003, Geneva: World Health Organisation, WHO/CDS/TB/2003.313. 2003, 3 WHO: Treatment of Tuberculosis: Guidelines for National Programmes. 2003, Geneva: World Health Organisation, WHO/CDS/TB/2003.313. 2003, 3
25.
go back to reference Crofton J: Clinical features of tuberculosis. Crofton and Douglas’s respiratory diseases. 1991, London: Wiley-Blackwell scientific, 4 Crofton J: Clinical features of tuberculosis. Crofton and Douglas’s respiratory diseases. 1991, London: Wiley-Blackwell scientific, 4
26.
go back to reference Hasan Z, Jamil B, Ashraf M, Islam M, Dojki M, Irfan M, Hussain R: Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and Culture filtrate protein 10-induced immunity in tuberculosis. Clin Vaccine Immunol. 2009, 16 (7): 991-998. 10.1128/CVI.00091-09.CrossRefPubMedPubMedCentral Hasan Z, Jamil B, Ashraf M, Islam M, Dojki M, Irfan M, Hussain R: Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and Culture filtrate protein 10-induced immunity in tuberculosis. Clin Vaccine Immunol. 2009, 16 (7): 991-998. 10.1128/CVI.00091-09.CrossRefPubMedPubMedCentral
27.
go back to reference Hasan Z, Cliff JM, Dockrell HM, Jamil B, Irfan M, Ashraf M, Hussain R: CCL2 Responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS One. 2009, 4 (12): e8459-10.1371/journal.pone.0008459.CrossRefPubMedPubMedCentral Hasan Z, Cliff JM, Dockrell HM, Jamil B, Irfan M, Ashraf M, Hussain R: CCL2 Responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS One. 2009, 4 (12): e8459-10.1371/journal.pone.0008459.CrossRefPubMedPubMedCentral
28.
go back to reference Masood KI, Rottenberg ME, Carow B, Rao N, Ashraf M, Hussain R, Hasan Z: SOCS1 Gene expression is increased in severe pulmonary tuberculosis. Scand J Immunol. 2012, 76 (4): 398-404. 10.1111/j.1365-3083.2012.02731.x.CrossRefPubMed Masood KI, Rottenberg ME, Carow B, Rao N, Ashraf M, Hussain R, Hasan Z: SOCS1 Gene expression is increased in severe pulmonary tuberculosis. Scand J Immunol. 2012, 76 (4): 398-404. 10.1111/j.1365-3083.2012.02731.x.CrossRefPubMed
29.
go back to reference Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A: Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques. 2004, 37 (1): 112-114. 116, 118–119PubMed Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A: Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques. 2004, 37 (1): 112-114. 116, 118–119PubMed
30.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.CrossRefPubMed Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.CrossRefPubMed
31.
go back to reference Talat N, Shahid F, Perry S, Dawood G, Hussain R: Th1/Th2 cytometric bead array can discriminate cytokine secretion from endogenously activated cells in pulmonary disease, recent and remote infection in tuberculosis. Cytokine. 2011, 54 (2): 136-143. 10.1016/j.cyto.2011.01.012.CrossRefPubMed Talat N, Shahid F, Perry S, Dawood G, Hussain R: Th1/Th2 cytometric bead array can discriminate cytokine secretion from endogenously activated cells in pulmonary disease, recent and remote infection in tuberculosis. Cytokine. 2011, 54 (2): 136-143. 10.1016/j.cyto.2011.01.012.CrossRefPubMed
32.
go back to reference Shiratsuchi H, Johnson JL, Ellner JJ: Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J Immunol. 1991, 146 (9): 3165-3170.PubMed Shiratsuchi H, Johnson JL, Ellner JJ: Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J Immunol. 1991, 146 (9): 3165-3170.PubMed
33.
go back to reference Gong JH, Zhang M, Modlin RL, Linsley PS, Iyer D, Lin Y, Barnes PF: Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun. 1996, 64 (3): 913-918.PubMedPubMedCentral Gong JH, Zhang M, Modlin RL, Linsley PS, Iyer D, Lin Y, Barnes PF: Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun. 1996, 64 (3): 913-918.PubMedPubMedCentral
34.
go back to reference Beamer GL, Flaherty DK, Assogba BD, Stromberg P, Gonzalez-Juarrero M, de Waal Malefyt R, Vesosky B, Turner J: Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol. 2008, 181 (8): 5545-5550.CrossRefPubMedPubMedCentral Beamer GL, Flaherty DK, Assogba BD, Stromberg P, Gonzalez-Juarrero M, de Waal Malefyt R, Vesosky B, Turner J: Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol. 2008, 181 (8): 5545-5550.CrossRefPubMedPubMedCentral
35.
go back to reference Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, Van Der Poll T: Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol. 1999, 115 (1): 110-113. 10.1046/j.1365-2249.1999.00783.x.CrossRefPubMedPubMedCentral Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, Van Der Poll T: Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol. 1999, 115 (1): 110-113. 10.1046/j.1365-2249.1999.00783.x.CrossRefPubMedPubMedCentral
36.
go back to reference Kursar M, Koch M, Mittrucker HW, Nouailles G, Bonhagen K, Kamradt T, Kaufmann SH: Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol. 2007, 178 (5): 2661-2665.CrossRefPubMed Kursar M, Koch M, Mittrucker HW, Nouailles G, Bonhagen K, Kamradt T, Kaufmann SH: Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol. 2007, 178 (5): 2661-2665.CrossRefPubMed
37.
go back to reference Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE: IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest. 2000, 105 (9): 1317-1325. 10.1172/JCI9918.CrossRefPubMedPubMedCentral Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE: IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest. 2000, 105 (9): 1317-1325. 10.1172/JCI9918.CrossRefPubMedPubMedCentral
38.
go back to reference Hasan Z, Mahmood A, Zafar S, Khan AA, Hussain R: Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses. Int J Lepr Other Mycobact Dis. 2004, 72 (1): 35-44. 10.1489/1544-581X(2004)072<0035:LPWLDH>2.0.CO;2.CrossRefPubMed Hasan Z, Mahmood A, Zafar S, Khan AA, Hussain R: Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses. Int J Lepr Other Mycobact Dis. 2004, 72 (1): 35-44. 10.1489/1544-581X(2004)072<0035:LPWLDH>2.0.CO;2.CrossRefPubMed
39.
go back to reference Antas PR, Sales JS, Pereira KC, Oliveira EB, Cunha KS, Sarno EN, Sampaio EP: Patterns of intracellular cytokines in CD4 and CD8 T cells from patients with mycobacterial infections. Braz J Med Biol Res. 2004, 37 (8): 1119-1129. 10.1590/S0100-879X2004000800003.CrossRefPubMed Antas PR, Sales JS, Pereira KC, Oliveira EB, Cunha KS, Sarno EN, Sampaio EP: Patterns of intracellular cytokines in CD4 and CD8 T cells from patients with mycobacterial infections. Braz J Med Biol Res. 2004, 37 (8): 1119-1129. 10.1590/S0100-879X2004000800003.CrossRefPubMed
40.
go back to reference Ferrand RA, Bothamley GH, Whelan A, Dockrell HM: Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2005, 9 (9): 1034-1039.PubMed Ferrand RA, Bothamley GH, Whelan A, Dockrell HM: Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2005, 9 (9): 1034-1039.PubMed
41.
go back to reference Egwuagu CE, Yu CR, Zhang M, Mahdi RM, Kim SJ, Gery I: Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol. 2002, 168 (7): 3181-3187.CrossRefPubMed Egwuagu CE, Yu CR, Zhang M, Mahdi RM, Kim SJ, Gery I: Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol. 2002, 168 (7): 3181-3187.CrossRefPubMed
42.
go back to reference Whyte CS, Bishop ET, Ruckerl D, Gaspar-Pereira S, Barker RN, Allen JE, Rees AJ, Wilson HM: Suppressor of Cytokine Signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol. 2011, 90 (5): 845-854. 10.1189/jlb.1110644.CrossRefPubMed Whyte CS, Bishop ET, Ruckerl D, Gaspar-Pereira S, Barker RN, Allen JE, Rees AJ, Wilson HM: Suppressor of Cytokine Signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol. 2011, 90 (5): 845-854. 10.1189/jlb.1110644.CrossRefPubMed
43.
go back to reference Hasan Z, Rao N, Salahuddin N, Islam M, Ashraf M, Rottenberg ME, Hussain R: M. tuberculosis sonicate induced IFN gamma, CXCL10 and IL-10 can differentiate severity in tuberculosis. Scand J Immunol. 2012, 74 (2): 220-226.CrossRef Hasan Z, Rao N, Salahuddin N, Islam M, Ashraf M, Rottenberg ME, Hussain R: M. tuberculosis sonicate induced IFN gamma, CXCL10 and IL-10 can differentiate severity in tuberculosis. Scand J Immunol. 2012, 74 (2): 220-226.CrossRef
44.
go back to reference Krebs DL, Hilton DJ: SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001, 19 (5): 378-387. 10.1634/stemcells.19-5-378.CrossRefPubMed Krebs DL, Hilton DJ: SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001, 19 (5): 378-387. 10.1634/stemcells.19-5-378.CrossRefPubMed
45.
go back to reference Liu Y, Stewart KN, Bishop E, Marek CJ, Kluth DC, Rees AJ, Wilson HM: Unique expression of Suppressor of Cytokine Signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo. J Immunol. 2008, 180 (9): 6270-6278.CrossRefPubMed Liu Y, Stewart KN, Bishop E, Marek CJ, Kluth DC, Rees AJ, Wilson HM: Unique expression of Suppressor of Cytokine Signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo. J Immunol. 2008, 180 (9): 6270-6278.CrossRefPubMed
Metadata
Title
Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis
Authors
Kiran I Masood
Martin E Rottenberg
Naseem Salahuddin
Muhammad Irfan
Nisar Rao
Berit Carow
Muniba Islam
Rabia Hussain
Zahra Hasan
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-13

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine